Literature DB >> 28886982

Management of Epilepsy Due to Hypothalamic Hamartomas.

Ayaz M Khawaja1, Sandipan Pati2, Yu-Tze Ng3.   

Abstract

A hypothalamic hamartoma consists of hyperplastic heterotopic tissue growing in a disorganized fashion. These lesions occur in about one per 50,000 to 100,000 people. Hypothalamic hamartomas can cause intrinsic epileptogenesis leading to gelastic seizures. Surrounding cortical structures may also develop secondary epileptogenesis. Persistent seizures caused by hypothalamic hamartomas can be debilitating and result in significant cognitive and behavioral impairment. Early recognition and treatment is important in controlling seizures and in preventing further cognitive deterioration. Some patients experience improved cognition and behavior following early treatment, suggesting that hypothalamic hamartomas represent a reversible epileptic encephalopathy. The outcome of epilepsy associated with these lesions has significantly evolved with the availability of new treatment techniques and an improved understanding of its pathogenesis. Increasing evidence supporting the role of hypothalamic hamartomas as a cause of gelastic seizures and secondary epileptogenesis has led to more frequent use of surgery as the definitive treatment. Several minimally invasive procedures have been devised, including neuroendoscopic approaches and different stereotactic radio and laser ablation techniques. Each of these techniques can lead to unique adverse events. We review the various classification schemes used to characterize hypothalamic hamartomas and the recommended surgical approaches for each subtype. We also review the literature for currently available treatment modalities and compare their efficacy in controlling seizures and their safety profiles.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  classifications; endoscopic surgery; gelastic seizures; hypothalamic hamartoma; stereotactic radiosurgery

Mesh:

Year:  2017        PMID: 28886982     DOI: 10.1016/j.pediatrneurol.2017.07.001

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  3 in total

1.  Bi-allelic SMO variants in hypothalamic hamartoma: a recessive cause of Pallister-Hall syndrome.

Authors:  Michael S Hildebrand; Samuel F Berkovic; Timothy E Green; Mareike Schimmel; Susanna Schubert; Johannes R Lemke; Mark F Bennett
Journal:  Eur J Hum Genet       Date:  2022-01-16       Impact factor: 4.246

2.  Description of a giant hypothalamic hamartoma associated with an immature ruptured giant sacrococcygeal teratoma: a case report.

Authors:  Nicolas Serratrice; Alice Faure; Andre Maues de Paula; Nadine Girard; Nicolas André; Didier Scavarda
Journal:  Childs Nerv Syst       Date:  2020-09-25       Impact factor: 1.475

3.  Long-term use of methylphenidate in a boy with hypothalamic tumor, drug-resistant epilepsy and ADHD.

Authors:  Dobrinko Socanski; Nebojsa Jovic; Harald Beneventi; Anita Herigstad
Journal:  Epilepsy Behav Case Rep       Date:  2018-04-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.